Connect Biopharma Holdings (CNTB) Treasury Shares (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Treasury Shares of $180000.0 for Q1 2026, little changed year-on-year from $180000.0 in Q1 2025, and little changed on a QoQ basis from $180000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Treasury Shares (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Treasury Shares for 2 consecutive years, with $2.1 million the latest figure, recorded in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $180000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $180000.0, changed 0.0% from the prior year.
- Treasury Shares was little changed at $180000.0 in Q1 2026 per CNTB's latest filing, from $180000.0 in the prior quarter.
- Over the last five years, Treasury Shares for CNTB reached as high as $180000.0 in Q4 2023 and fell as low as $161000.0 in Q2 2023.
- A 5-year average of $176151.2 and a median of $180000.0 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares decreased 10.11% — and 2024, when it climbed 11.8%.
- Year by year, Treasury Shares stood at $163663.1 in 2022, then climbed by 9.98% to $180000.0 in 2023, then changed by 0.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025, then changed by 0.0% to $180000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $180000.0, $180000.0, and $180000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | - |
| 10 | Connect Biopharma Holdings | 122.70 Mn | 122.70 Mn | - | 180,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180,000.00 |
| Mar 31, 2026 | 180,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | 180,000.00 |
| Sep 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 180,000.00 |
| Mar 31, 2025 | 180,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Dec 31, 2024 | 2.51 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Jun 30, 2024 | 180,000.00 |
| Jun 30, 2024 | 180,000.00 |
| Dec 31, 2023 | 180,000.00 |
| Dec 31, 2023 | 180,000.00 |